Endeavor

A Lasting Legacy

Through the Rapid Tissue Donation Program, patients can help save lives, even after their death

New Oral Drug Shows Promise for Patients with HER2-Mutated Lung Cancer

Beamion LUNG-1 trial results highlight zongertinib’s strong tumor control and durable responses

Experimental Drug Shows Promise for Patients With Rare Lung Cancer Mutation

New drug targets active form of KRAS, offering hope for lung cancer patients

New Drug Combination Targets KRAS Mutations in Lung Cancer

Study looks at a new way to fight back when KRAS-targeted drugs stop working

How Do Adaptable Cancer Cells Outsmart Treatment?

Moffitt study explores how cancer cells adapt to survive therapy and how stopping that adaptability could lead to better outcomes

Moffitt Study Shows New Immune Boost Could Expand Access to Cancer Immunotherapy

Adding a natural protein improves the speed and success of TIL manufacturing, potentially benefiting more patients

Study Shows Increase in Lung Cancer Screening After Guideline Changes

Around 47% of eligible participants underwent screening after changes in recommendations

Former Nurse Credits Moffitt for Saving Her Life Twice

Casiana Hilton survived breast and lung cancers thanks to early detection and the skilled surgeons at Moffitt.

Wheels of Hope: Team Members Drive to End Lung Cancer

The team behind Florida’s first mobile lung cancer screening unit focuses on saving lives